Global Psychedelic Drugs Market 2024 by Company, Regions, Type and Application, Forecast to 2030
Page: 151
Published Date: 03 Jan 2024
Category: Medical Care
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
According to our (Global Info Research) latest study, the global Psychedelic Drugs market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Psychedelic Drugs industry chain, the market status of Depressive Disorders (Psilocybin, LSD), Post-Traumatic Stress Disorders (Psilocybin, LSD), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Psychedelic Drugs.
Regionally, the report analyzes the Psychedelic Drugs markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Psychedelic Drugs market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Psychedelic Drugs market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Psychedelic Drugs industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Psilocybin, LSD).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Psychedelic Drugs market.
Regional Analysis: The report involves examining the Psychedelic Drugs market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Psychedelic Drugs market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Psychedelic Drugs:
Company Analysis: Report covers individual Psychedelic Drugs players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Psychedelic Drugs This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Depressive Disorders, Post-Traumatic Stress Disorders).
Technology Analysis: Report covers specific technologies relevant to Psychedelic Drugs. It assesses the current state, advancements, and potential future developments in Psychedelic Drugs areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Psychedelic Drugs market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Psychedelic Drugs market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Psilocybin
LSD
MDMA
DMT
Ketamine
Others
Market segment by Application
Depressive Disorders
Post-Traumatic Stress Disorders
Substance Abuse Disorders
Obsessive Compulsive Disorders
Others
Market segment by players, this report covers
COMPASS Pathways PLC
Pfizer
Eli Lilly
GlaxoSmithKline
Cybin Inc
Field Trip Health
ATAI Life Sciences
NUMINUS WELLNESS
MindMed
HAVN Life Sciences
Seelos Therapeutics
Jannsen
Acadia Pharmaceuticals
Intellipharmaceutics
Revive Therapeutics
Mydecine Innovations Group
Red Light Holland
Braxia Scientific
Mind Cure Health
Entheon Biomedical
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Psychedelic Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Psychedelic Drugs, with revenue, gross margin and global market share of Psychedelic Drugs from 2019 to 2024.
Chapter 3, the Psychedelic Drugs competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Psychedelic Drugs market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Psychedelic Drugs.
Chapter 13, to describe Psychedelic Drugs research findings and conclusion.
Table of Contents
1 Market Overview
1.1 Product Overview and Scope of Psychedelic Drugs
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Psychedelic Drugs by Type
1.3.1 Overview: Global Psychedelic Drugs Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Psychedelic Drugs Consumption Value Market Share by Type in 2023
1.3.3 Psilocybin
1.3.4 LSD
1.3.5 MDMA
1.3.6 DMT
1.3.7 Ketamine
1.3.8 Others
1.4 Global Psychedelic Drugs Market by Application
1.4.1 Overview: Global Psychedelic Drugs Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Depressive Disorders
1.4.3 Post-Traumatic Stress Disorders
1.4.4 Substance Abuse Disorders
1.4.5 Obsessive Compulsive Disorders
1.4.6 Others
1.5 Global Psychedelic Drugs Market Size & Forecast
1.6 Global Psychedelic Drugs Market Size and Forecast by Region
1.6.1 Global Psychedelic Drugs Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Psychedelic Drugs Market Size by Region, (2019-2030)
1.6.3 North America Psychedelic Drugs Market Size and Prospect (2019-2030)
1.6.4 Europe Psychedelic Drugs Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Psychedelic Drugs Market Size and Prospect (2019-2030)
1.6.6 South America Psychedelic Drugs Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Psychedelic Drugs Market Size and Prospect (2019-2030)
2.1 COMPASS Pathways PLC
2.1.1 COMPASS Pathways PLC Details
2.1.2 COMPASS Pathways PLC Major Business
2.1.3 COMPASS Pathways PLC Psychedelic Drugs Product and Solutions
2.1.4 COMPASS Pathways PLC Psychedelic Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 COMPASS Pathways PLC Recent Developments and Future Plans
2.2 Pfizer
2.2.1 Pfizer Details
2.2.2 Pfizer Major Business
2.2.3 Pfizer Psychedelic Drugs Product and Solutions
2.2.4 Pfizer Psychedelic Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Pfizer Recent Developments and Future Plans
2.3 Eli Lilly
2.3.1 Eli Lilly Details
2.3.2 Eli Lilly Major Business
2.3.3 Eli Lilly Psychedelic Drugs Product and Solutions
2.3.4 Eli Lilly Psychedelic Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Eli Lilly Recent Developments and Future Plans
2.4 GlaxoSmithKline
2.4.1 GlaxoSmithKline Details
2.4.2 GlaxoSmithKline Major Business
2.4.3 GlaxoSmithKline Psychedelic Drugs Product and Solutions
2.4.4 GlaxoSmithKline Psychedelic Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 GlaxoSmithKline Recent Developments and Future Plans
2.5 Cybin Inc
2.5.1 Cybin Inc Details
2.5.2 Cybin Inc Major Business
2.5.3 Cybin Inc Psychedelic Drugs Product and Solutions
2.5.4 Cybin Inc Psychedelic Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Cybin Inc Recent Developments and Future Plans
2.6 Field Trip Health
2.6.1 Field Trip Health Details
2.6.2 Field Trip Health Major Business
2.6.3 Field Trip Health Psychedelic Drugs Product and Solutions
2.6.4 Field Trip Health Psychedelic Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Field Trip Health Recent Developments and Future Plans
2.7 ATAI Life Sciences
2.7.1 ATAI Life Sciences Details
2.7.2 ATAI Life Sciences Major Business
2.7.3 ATAI Life Sciences Psychedelic Drugs Product and Solutions
2.7.4 ATAI Life Sciences Psychedelic Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 ATAI Life Sciences Recent Developments and Future Plans
2.8 NUMINUS WELLNESS
2.8.1 NUMINUS WELLNESS Details
2.8.2 NUMINUS WELLNESS Major Business
2.8.3 NUMINUS WELLNESS Psychedelic Drugs Product and Solutions
2.8.4 NUMINUS WELLNESS Psychedelic Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 NUMINUS WELLNESS Recent Developments and Future Plans
2.9 MindMed
2.9.1 MindMed Details
2.9.2 MindMed Major Business
2.9.3 MindMed Psychedelic Drugs Product and Solutions
2.9.4 MindMed Psychedelic Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 MindMed Recent Developments and Future Plans
2.10 HAVN Life Sciences
2.10.1 HAVN Life Sciences Details
2.10.2 HAVN Life Sciences Major Business
2.10.3 HAVN Life Sciences Psychedelic Drugs Product and Solutions
2.10.4 HAVN Life Sciences Psychedelic Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 HAVN Life Sciences Recent Developments and Future Plans
2.11 Seelos Therapeutics
2.11.1 Seelos Therapeutics Details
2.11.2 Seelos Therapeutics Major Business
2.11.3 Seelos Therapeutics Psychedelic Drugs Product and Solutions
2.11.4 Seelos Therapeutics Psychedelic Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Seelos Therapeutics Recent Developments and Future Plans
2.12 Jannsen
2.12.1 Jannsen Details
2.12.2 Jannsen Major Business
2.12.3 Jannsen Psychedelic Drugs Product and Solutions
2.12.4 Jannsen Psychedelic Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Jannsen Recent Developments and Future Plans
2.13 Acadia Pharmaceuticals
2.13.1 Acadia Pharmaceuticals Details
2.13.2 Acadia Pharmaceuticals Major Business
2.13.3 Acadia Pharmaceuticals Psychedelic Drugs Product and Solutions
2.13.4 Acadia Pharmaceuticals Psychedelic Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Acadia Pharmaceuticals Recent Developments and Future Plans
2.14 Intellipharmaceutics
2.14.1 Intellipharmaceutics Details
2.14.2 Intellipharmaceutics Major Business
2.14.3 Intellipharmaceutics Psychedelic Drugs Product and Solutions
2.14.4 Intellipharmaceutics Psychedelic Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 Intellipharmaceutics Recent Developments and Future Plans
2.15 Revive Therapeutics
2.15.1 Revive Therapeutics Details
2.15.2 Revive Therapeutics Major Business
2.15.3 Revive Therapeutics Psychedelic Drugs Product and Solutions
2.15.4 Revive Therapeutics Psychedelic Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.15.5 Revive Therapeutics Recent Developments and Future Plans
2.16 Mydecine Innovations Group
2.16.1 Mydecine Innovations Group Details
2.16.2 Mydecine Innovations Group Major Business
2.16.3 Mydecine Innovations Group Psychedelic Drugs Product and Solutions
2.16.4 Mydecine Innovations Group Psychedelic Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.16.5 Mydecine Innovations Group Recent Developments and Future Plans
2.17 Red Light Holland
2.17.1 Red Light Holland Details
2.17.2 Red Light Holland Major Business
2.17.3 Red Light Holland Psychedelic Drugs Product and Solutions
2.17.4 Red Light Holland Psychedelic Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.17.5 Red Light Holland Recent Developments and Future Plans
2.18 Braxia Scientific
2.18.1 Braxia Scientific Details
2.18.2 Braxia Scientific Major Business
2.18.3 Braxia Scientific Psychedelic Drugs Product and Solutions
2.18.4 Braxia Scientific Psychedelic Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.18.5 Braxia Scientific Recent Developments and Future Plans
2.19 Mind Cure Health
2.19.1 Mind Cure Health Details
2.19.2 Mind Cure Health Major Business
2.19.3 Mind Cure Health Psychedelic Drugs Product and Solutions
2.19.4 Mind Cure Health Psychedelic Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.19.5 Mind Cure Health Recent Developments and Future Plans
2.20 Entheon Biomedical
2.20.1 Entheon Biomedical Details
2.20.2 Entheon Biomedical Major Business
2.20.3 Entheon Biomedical Psychedelic Drugs Product and Solutions
2.20.4 Entheon Biomedical Psychedelic Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.20.5 Entheon Biomedical Recent Developments and Future Plans
3.1 Global Psychedelic Drugs Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Psychedelic Drugs by Company Revenue
3.2.2 Top 3 Psychedelic Drugs Players Market Share in 2023
3.2.3 Top 6 Psychedelic Drugs Players Market Share in 2023
3.3 Psychedelic Drugs Market: Overall Company Footprint Analysis
3.3.1 Psychedelic Drugs Market: Region Footprint
3.3.2 Psychedelic Drugs Market: Company Product Type Footprint
3.3.3 Psychedelic Drugs Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4.1 Global Psychedelic Drugs Consumption Value and Market Share by Type (2019-2024)
4.2 Global Psychedelic Drugs Market Forecast by Type (2025-2030)
5.1 Global Psychedelic Drugs Consumption Value Market Share by Application (2019-2024)
5.2 Global Psychedelic Drugs Market Forecast by Application (2025-2030)
6.1 North America Psychedelic Drugs Consumption Value by Type (2019-2030)
6.2 North America Psychedelic Drugs Consumption Value by Application (2019-2030)
6.3 North America Psychedelic Drugs Market Size by Country
6.3.1 North America Psychedelic Drugs Consumption Value by Country (2019-2030)
6.3.2 United States Psychedelic Drugs Market Size and Forecast (2019-2030)
6.3.3 Canada Psychedelic Drugs Market Size and Forecast (2019-2030)
6.3.4 Mexico Psychedelic Drugs Market Size and Forecast (2019-2030)
7.1 Europe Psychedelic Drugs Consumption Value by Type (2019-2030)
7.2 Europe Psychedelic Drugs Consumption Value by Application (2019-2030)
7.3 Europe Psychedelic Drugs Market Size by Country
7.3.1 Europe Psychedelic Drugs Consumption Value by Country (2019-2030)
7.3.2 Germany Psychedelic Drugs Market Size and Forecast (2019-2030)
7.3.3 France Psychedelic Drugs Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Psychedelic Drugs Market Size and Forecast (2019-2030)
7.3.5 Russia Psychedelic Drugs Market Size and Forecast (2019-2030)
7.3.6 Italy Psychedelic Drugs Market Size and Forecast (2019-2030)
8.1 Asia-Pacific Psychedelic Drugs Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Psychedelic Drugs Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Psychedelic Drugs Market Size by Region
8.3.1 Asia-Pacific Psychedelic Drugs Consumption Value by Region (2019-2030)
8.3.2 China Psychedelic Drugs Market Size and Forecast (2019-2030)
8.3.3 Japan Psychedelic Drugs Market Size and Forecast (2019-2030)
8.3.4 South Korea Psychedelic Drugs Market Size and Forecast (2019-2030)
8.3.5 India Psychedelic Drugs Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Psychedelic Drugs Market Size and Forecast (2019-2030)
8.3.7 Australia Psychedelic Drugs Market Size and Forecast (2019-2030)
9.1 South America Psychedelic Drugs Consumption Value by Type (2019-2030)
9.2 South America Psychedelic Drugs Consumption Value by Application (2019-2030)
9.3 South America Psychedelic Drugs Market Size by Country
9.3.1 South America Psychedelic Drugs Consumption Value by Country (2019-2030)
9.3.2 Brazil Psychedelic Drugs Market Size and Forecast (2019-2030)
9.3.3 Argentina Psychedelic Drugs Market Size and Forecast (2019-2030)
10.1 Middle East & Africa Psychedelic Drugs Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Psychedelic Drugs Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Psychedelic Drugs Market Size by Country
10.3.1 Middle East & Africa Psychedelic Drugs Consumption Value by Country (2019-2030)
10.3.2 Turkey Psychedelic Drugs Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Psychedelic Drugs Market Size and Forecast (2019-2030)
10.3.4 UAE Psychedelic Drugs Market Size and Forecast (2019-2030)
11.1 Psychedelic Drugs Market Drivers
11.2 Psychedelic Drugs Market Restraints
11.3 Psychedelic Drugs Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12.1 Psychedelic Drugs Industry Chain
12.2 Psychedelic Drugs Upstream Analysis
12.3 Psychedelic Drugs Midstream Analysis
12.4 Psychedelic Drugs Downstream Analysis
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table of Figures
List of Tables
Table 1. Global Psychedelic Drugs Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Psychedelic Drugs Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Psychedelic Drugs Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Psychedelic Drugs Consumption Value by Region (2025-2030) & (USD Million)
Table 5. COMPASS Pathways PLC Company Information, Head Office, and Major Competitors
Table 6. COMPASS Pathways PLC Major Business
Table 7. COMPASS Pathways PLC Psychedelic Drugs Product and Solutions
Table 8. COMPASS Pathways PLC Psychedelic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. COMPASS Pathways PLC Recent Developments and Future Plans
Table 10. Pfizer Company Information, Head Office, and Major Competitors
Table 11. Pfizer Major Business
Table 12. Pfizer Psychedelic Drugs Product and Solutions
Table 13. Pfizer Psychedelic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Pfizer Recent Developments and Future Plans
Table 15. Eli Lilly Company Information, Head Office, and Major Competitors
Table 16. Eli Lilly Major Business
Table 17. Eli Lilly Psychedelic Drugs Product and Solutions
Table 18. Eli Lilly Psychedelic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Eli Lilly Recent Developments and Future Plans
Table 20. GlaxoSmithKline Company Information, Head Office, and Major Competitors
Table 21. GlaxoSmithKline Major Business
Table 22. GlaxoSmithKline Psychedelic Drugs Product and Solutions
Table 23. GlaxoSmithKline Psychedelic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. GlaxoSmithKline Recent Developments and Future Plans
Table 25. Cybin Inc Company Information, Head Office, and Major Competitors
Table 26. Cybin Inc Major Business
Table 27. Cybin Inc Psychedelic Drugs Product and Solutions
Table 28. Cybin Inc Psychedelic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. Cybin Inc Recent Developments and Future Plans
Table 30. Field Trip Health Company Information, Head Office, and Major Competitors
Table 31. Field Trip Health Major Business
Table 32. Field Trip Health Psychedelic Drugs Product and Solutions
Table 33. Field Trip Health Psychedelic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Field Trip Health Recent Developments and Future Plans
Table 35. ATAI Life Sciences Company Information, Head Office, and Major Competitors
Table 36. ATAI Life Sciences Major Business
Table 37. ATAI Life Sciences Psychedelic Drugs Product and Solutions
Table 38. ATAI Life Sciences Psychedelic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. ATAI Life Sciences Recent Developments and Future Plans
Table 40. NUMINUS WELLNESS Company Information, Head Office, and Major Competitors
Table 41. NUMINUS WELLNESS Major Business
Table 42. NUMINUS WELLNESS Psychedelic Drugs Product and Solutions
Table 43. NUMINUS WELLNESS Psychedelic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. NUMINUS WELLNESS Recent Developments and Future Plans
Table 45. MindMed Company Information, Head Office, and Major Competitors
Table 46. MindMed Major Business
Table 47. MindMed Psychedelic Drugs Product and Solutions
Table 48. MindMed Psychedelic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. MindMed Recent Developments and Future Plans
Table 50. HAVN Life Sciences Company Information, Head Office, and Major Competitors
Table 51. HAVN Life Sciences Major Business
Table 52. HAVN Life Sciences Psychedelic Drugs Product and Solutions
Table 53. HAVN Life Sciences Psychedelic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. HAVN Life Sciences Recent Developments and Future Plans
Table 55. Seelos Therapeutics Company Information, Head Office, and Major Competitors
Table 56. Seelos Therapeutics Major Business
Table 57. Seelos Therapeutics Psychedelic Drugs Product and Solutions
Table 58. Seelos Therapeutics Psychedelic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 59. Seelos Therapeutics Recent Developments and Future Plans
Table 60. Jannsen Company Information, Head Office, and Major Competitors
Table 61. Jannsen Major Business
Table 62. Jannsen Psychedelic Drugs Product and Solutions
Table 63. Jannsen Psychedelic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 64. Jannsen Recent Developments and Future Plans
Table 65. Acadia Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 66. Acadia Pharmaceuticals Major Business
Table 67. Acadia Pharmaceuticals Psychedelic Drugs Product and Solutions
Table 68. Acadia Pharmaceuticals Psychedelic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 69. Acadia Pharmaceuticals Recent Developments and Future Plans
Table 70. Intellipharmaceutics Company Information, Head Office, and Major Competitors
Table 71. Intellipharmaceutics Major Business
Table 72. Intellipharmaceutics Psychedelic Drugs Product and Solutions
Table 73. Intellipharmaceutics Psychedelic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 74. Intellipharmaceutics Recent Developments and Future Plans
Table 75. Revive Therapeutics Company Information, Head Office, and Major Competitors
Table 76. Revive Therapeutics Major Business
Table 77. Revive Therapeutics Psychedelic Drugs Product and Solutions
Table 78. Revive Therapeutics Psychedelic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 79. Revive Therapeutics Recent Developments and Future Plans
Table 80. Mydecine Innovations Group Company Information, Head Office, and Major Competitors
Table 81. Mydecine Innovations Group Major Business
Table 82. Mydecine Innovations Group Psychedelic Drugs Product and Solutions
Table 83. Mydecine Innovations Group Psychedelic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 84. Mydecine Innovations Group Recent Developments and Future Plans
Table 85. Red Light Holland Company Information, Head Office, and Major Competitors
Table 86. Red Light Holland Major Business
Table 87. Red Light Holland Psychedelic Drugs Product and Solutions
Table 88. Red Light Holland Psychedelic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 89. Red Light Holland Recent Developments and Future Plans
Table 90. Braxia Scientific Company Information, Head Office, and Major Competitors
Table 91. Braxia Scientific Major Business
Table 92. Braxia Scientific Psychedelic Drugs Product and Solutions
Table 93. Braxia Scientific Psychedelic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 94. Braxia Scientific Recent Developments and Future Plans
Table 95. Mind Cure Health Company Information, Head Office, and Major Competitors
Table 96. Mind Cure Health Major Business
Table 97. Mind Cure Health Psychedelic Drugs Product and Solutions
Table 98. Mind Cure Health Psychedelic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 99. Mind Cure Health Recent Developments and Future Plans
Table 100. Entheon Biomedical Company Information, Head Office, and Major Competitors
Table 101. Entheon Biomedical Major Business
Table 102. Entheon Biomedical Psychedelic Drugs Product and Solutions
Table 103. Entheon Biomedical Psychedelic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 104. Entheon Biomedical Recent Developments and Future Plans
Table 105. Global Psychedelic Drugs Revenue (USD Million) by Players (2019-2024)
Table 106. Global Psychedelic Drugs Revenue Share by Players (2019-2024)
Table 107. Breakdown of Psychedelic Drugs by Company Type (Tier 1, Tier 2, and Tier 3)
Table 108. Market Position of Players in Psychedelic Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 109. Head Office of Key Psychedelic Drugs Players
Table 110. Psychedelic Drugs Market: Company Product Type Footprint
Table 111. Psychedelic Drugs Market: Company Product Application Footprint
Table 112. Psychedelic Drugs New Market Entrants and Barriers to Market Entry
Table 113. Psychedelic Drugs Mergers, Acquisition, Agreements, and Collaborations
Table 114. Global Psychedelic Drugs Consumption Value (USD Million) by Type (2019-2024)
Table 115. Global Psychedelic Drugs Consumption Value Share by Type (2019-2024)
Table 116. Global Psychedelic Drugs Consumption Value Forecast by Type (2025-2030)
Table 117. Global Psychedelic Drugs Consumption Value by Application (2019-2024)
Table 118. Global Psychedelic Drugs Consumption Value Forecast by Application (2025-2030)
Table 119. North America Psychedelic Drugs Consumption Value by Type (2019-2024) & (USD Million)
Table 120. North America Psychedelic Drugs Consumption Value by Type (2025-2030) & (USD Million)
Table 121. North America Psychedelic Drugs Consumption Value by Application (2019-2024) & (USD Million)
Table 122. North America Psychedelic Drugs Consumption Value by Application (2025-2030) & (USD Million)
Table 123. North America Psychedelic Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 124. North America Psychedelic Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 125. Europe Psychedelic Drugs Consumption Value by Type (2019-2024) & (USD Million)
Table 126. Europe Psychedelic Drugs Consumption Value by Type (2025-2030) & (USD Million)
Table 127. Europe Psychedelic Drugs Consumption Value by Application (2019-2024) & (USD Million)
Table 128. Europe Psychedelic Drugs Consumption Value by Application (2025-2030) & (USD Million)
Table 129. Europe Psychedelic Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 130. Europe Psychedelic Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 131. Asia-Pacific Psychedelic Drugs Consumption Value by Type (2019-2024) & (USD Million)
Table 132. Asia-Pacific Psychedelic Drugs Consumption Value by Type (2025-2030) & (USD Million)
Table 133. Asia-Pacific Psychedelic Drugs Consumption Value by Application (2019-2024) & (USD Million)
Table 134. Asia-Pacific Psychedelic Drugs Consumption Value by Application (2025-2030) & (USD Million)
Table 135. Asia-Pacific Psychedelic Drugs Consumption Value by Region (2019-2024) & (USD Million)
Table 136. Asia-Pacific Psychedelic Drugs Consumption Value by Region (2025-2030) & (USD Million)
Table 137. South America Psychedelic Drugs Consumption Value by Type (2019-2024) & (USD Million)
Table 138. South America Psychedelic Drugs Consumption Value by Type (2025-2030) & (USD Million)
Table 139. South America Psychedelic Drugs Consumption Value by Application (2019-2024) & (USD Million)
Table 140. South America Psychedelic Drugs Consumption Value by Application (2025-2030) & (USD Million)
Table 141. South America Psychedelic Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 142. South America Psychedelic Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 143. Middle East & Africa Psychedelic Drugs Consumption Value by Type (2019-2024) & (USD Million)
Table 144. Middle East & Africa Psychedelic Drugs Consumption Value by Type (2025-2030) & (USD Million)
Table 145. Middle East & Africa Psychedelic Drugs Consumption Value by Application (2019-2024) & (USD Million)
Table 146. Middle East & Africa Psychedelic Drugs Consumption Value by Application (2025-2030) & (USD Million)
Table 147. Middle East & Africa Psychedelic Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 148. Middle East & Africa Psychedelic Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 149. Psychedelic Drugs Raw Material
Table 150. Key Suppliers of Psychedelic Drugs Raw Materials
List of Figures
Figure 1. Psychedelic Drugs Picture
Figure 2. Global Psychedelic Drugs Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Psychedelic Drugs Consumption Value Market Share by Type in 2023
Figure 4. Psilocybin
Figure 5. LSD
Figure 6. MDMA
Figure 7. DMT
Figure 8. Ketamine
Figure 9. Others
Figure 10. Global Psychedelic Drugs Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 11. Psychedelic Drugs Consumption Value Market Share by Application in 2023
Figure 12. Depressive Disorders Picture
Figure 13. Post-Traumatic Stress Disorders Picture
Figure 14. Substance Abuse Disorders Picture
Figure 15. Obsessive Compulsive Disorders Picture
Figure 16. Others Picture
Figure 17. Global Psychedelic Drugs Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 18. Global Psychedelic Drugs Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 19. Global Market Psychedelic Drugs Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 20. Global Psychedelic Drugs Consumption Value Market Share by Region (2019-2030)
Figure 21. Global Psychedelic Drugs Consumption Value Market Share by Region in 2023
Figure 22. North America Psychedelic Drugs Consumption Value (2019-2030) & (USD Million)
Figure 23. Europe Psychedelic Drugs Consumption Value (2019-2030) & (USD Million)
Figure 24. Asia-Pacific Psychedelic Drugs Consumption Value (2019-2030) & (USD Million)
Figure 25. South America Psychedelic Drugs Consumption Value (2019-2030) & (USD Million)
Figure 26. Middle East and Africa Psychedelic Drugs Consumption Value (2019-2030) & (USD Million)
Figure 27. Global Psychedelic Drugs Revenue Share by Players in 2023
Figure 28. Psychedelic Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 29. Global Top 3 Players Psychedelic Drugs Market Share in 2023
Figure 30. Global Top 6 Players Psychedelic Drugs Market Share in 2023
Figure 31. Global Psychedelic Drugs Consumption Value Share by Type (2019-2024)
Figure 32. Global Psychedelic Drugs Market Share Forecast by Type (2025-2030)
Figure 33. Global Psychedelic Drugs Consumption Value Share by Application (2019-2024)
Figure 34. Global Psychedelic Drugs Market Share Forecast by Application (2025-2030)
Figure 35. North America Psychedelic Drugs Consumption Value Market Share by Type (2019-2030)
Figure 36. North America Psychedelic Drugs Consumption Value Market Share by Application (2019-2030)
Figure 37. North America Psychedelic Drugs Consumption Value Market Share by Country (2019-2030)
Figure 38. United States Psychedelic Drugs Consumption Value (2019-2030) & (USD Million)
Figure 39. Canada Psychedelic Drugs Consumption Value (2019-2030) & (USD Million)
Figure 40. Mexico Psychedelic Drugs Consumption Value (2019-2030) & (USD Million)
Figure 41. Europe Psychedelic Drugs Consumption Value Market Share by Type (2019-2030)
Figure 42. Europe Psychedelic Drugs Consumption Value Market Share by Application (2019-2030)
Figure 43. Europe Psychedelic Drugs Consumption Value Market Share by Country (2019-2030)
Figure 44. Germany Psychedelic Drugs Consumption Value (2019-2030) & (USD Million)
Figure 45. France Psychedelic Drugs Consumption Value (2019-2030) & (USD Million)
Figure 46. United Kingdom Psychedelic Drugs Consumption Value (2019-2030) & (USD Million)
Figure 47. Russia Psychedelic Drugs Consumption Value (2019-2030) & (USD Million)
Figure 48. Italy Psychedelic Drugs Consumption Value (2019-2030) & (USD Million)
Figure 49. Asia-Pacific Psychedelic Drugs Consumption Value Market Share by Type (2019-2030)
Figure 50. Asia-Pacific Psychedelic Drugs Consumption Value Market Share by Application (2019-2030)
Figure 51. Asia-Pacific Psychedelic Drugs Consumption Value Market Share by Region (2019-2030)
Figure 52. China Psychedelic Drugs Consumption Value (2019-2030) & (USD Million)
Figure 53. Japan Psychedelic Drugs Consumption Value (2019-2030) & (USD Million)
Figure 54. South Korea Psychedelic Drugs Consumption Value (2019-2030) & (USD Million)
Figure 55. India Psychedelic Drugs Consumption Value (2019-2030) & (USD Million)
Figure 56. Southeast Asia Psychedelic Drugs Consumption Value (2019-2030) & (USD Million)
Figure 57. Australia Psychedelic Drugs Consumption Value (2019-2030) & (USD Million)
Figure 58. South America Psychedelic Drugs Consumption Value Market Share by Type (2019-2030)
Figure 59. South America Psychedelic Drugs Consumption Value Market Share by Application (2019-2030)
Figure 60. South America Psychedelic Drugs Consumption Value Market Share by Country (2019-2030)
Figure 61. Brazil Psychedelic Drugs Consumption Value (2019-2030) & (USD Million)
Figure 62. Argentina Psychedelic Drugs Consumption Value (2019-2030) & (USD Million)
Figure 63. Middle East and Africa Psychedelic Drugs Consumption Value Market Share by Type (2019-2030)
Figure 64. Middle East and Africa Psychedelic Drugs Consumption Value Market Share by Application (2019-2030)
Figure 65. Middle East and Africa Psychedelic Drugs Consumption Value Market Share by Country (2019-2030)
Figure 66. Turkey Psychedelic Drugs Consumption Value (2019-2030) & (USD Million)
Figure 67. Saudi Arabia Psychedelic Drugs Consumption Value (2019-2030) & (USD Million)
Figure 68. UAE Psychedelic Drugs Consumption Value (2019-2030) & (USD Million)
Figure 69. Psychedelic Drugs Market Drivers
Figure 70. Psychedelic Drugs Market Restraints
Figure 71. Psychedelic Drugs Market Trends
Figure 72. Porters Five Forces Analysis
Figure 73. Manufacturing Cost Structure Analysis of Psychedelic Drugs in 2023
Figure 74. Manufacturing Process Analysis of Psychedelic Drugs
Figure 75. Psychedelic Drugs Industrial Chain
Figure 76. Methodology
Figure 77. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
COMPASS Pathways PLC Pfizer Eli Lilly GlaxoSmithKline Cybin Inc Field Trip Health ATAI Life Sciences NUMINUS WELLNESS MindMed HAVN Life Sciences Seelos Therapeutics Jannsen Acadia Pharmaceuticals Intellipharmaceutics Revive Therapeutics Mydecine Innovations Group Red Light Holland Braxia Scientific Mind Cure Health Entheon Biomedical
Related Reports
23 Jan 2023
Medical Care
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
